Adaptimmune Therapeutics Plc ADR (ADAPY)

$0.05 0.00 (-1.82%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA (famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment of synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 12 3543 0000
Address:
60 Jubilee Avenue, Milton Park, Abingdon, United Kingdom
Reflexwarrior
Reflexwarrior Apr. 5 at 4:03 PM
$ADAPY basically. Wait. You wont be dissapointed
0 · Reply
US_Bull
US_Bull Apr. 5 at 3:04 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Apr. 5 at 3:00 PM
$ADAPY ChatGPT sees a much greater overlap and connection to IMCR than Greywolf Therapeutics. I did different search strategies whether they have ever co-authored scientific publications/abstracts/overlap between people working at different companies shifting to the other companies and many more searching parameters. Even though there is an overlap between targeting ERAP-1 and ERAP-2 inhibitors and MAGE and PRAME (see below). But then again IMCR dropped a clinical study targeting the exact targets that lete-cel targets. https://pmc.ncbi.nlm.nih.gov/articles/PMC12047507/
1 · Reply
Damage111
Damage111 Apr. 4 at 7:12 PM
$ADAPY hoping this week brings us some good news 💵
0 · Reply
BK217
BK217 Apr. 4 at 12:03 AM
$ADAPY I was told my an informed authority that the fact the ADR fee wasn’t collected was a clear sign that a “corporate action” was right around the corner The hilarious thing about this is that no retail can sell but they can keep charging ADR fees in perpetuity You guys are all so fucking stupid it boggles the mind Fortunately I cleared about 500k this week in gainz on nectar so 4k or so is but a mere irritant But still!
1 · Reply
Dipshit101
Dipshit101 Apr. 3 at 5:37 PM
$ADAPY please someone explained to the dipshits, what’s the process here, when/if the outcome is one we get paid, Is it put in our accounts? Or does the share prices just go up and we decide when to sell ?
1 · Reply
US_Bull
US_Bull Apr. 3 at 2:53 PM
$ADAPY Look under IND enabling for both us and them (their's is undisclosed) is it supposed to be ADAPY's. https://www.greywolftherapeutics.com/pipeline https://www.adaptimmune.com/pipeline
0 · Reply
US_Bull
US_Bull Apr. 3 at 2:45 PM
$ADAPY Whole premise of Adaptimmune is to target MAGE, PRAME, and CD70
1 · Reply
US_Bull
US_Bull Apr. 3 at 2:43 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Apr. 3 at 2:40 PM
$ADAPY
0 · Reply
Latest News on ADAPY
No data available.
Reflexwarrior
Reflexwarrior Apr. 5 at 4:03 PM
$ADAPY basically. Wait. You wont be dissapointed
0 · Reply
US_Bull
US_Bull Apr. 5 at 3:04 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Apr. 5 at 3:00 PM
$ADAPY ChatGPT sees a much greater overlap and connection to IMCR than Greywolf Therapeutics. I did different search strategies whether they have ever co-authored scientific publications/abstracts/overlap between people working at different companies shifting to the other companies and many more searching parameters. Even though there is an overlap between targeting ERAP-1 and ERAP-2 inhibitors and MAGE and PRAME (see below). But then again IMCR dropped a clinical study targeting the exact targets that lete-cel targets. https://pmc.ncbi.nlm.nih.gov/articles/PMC12047507/
1 · Reply
Damage111
Damage111 Apr. 4 at 7:12 PM
$ADAPY hoping this week brings us some good news 💵
0 · Reply
BK217
BK217 Apr. 4 at 12:03 AM
$ADAPY I was told my an informed authority that the fact the ADR fee wasn’t collected was a clear sign that a “corporate action” was right around the corner The hilarious thing about this is that no retail can sell but they can keep charging ADR fees in perpetuity You guys are all so fucking stupid it boggles the mind Fortunately I cleared about 500k this week in gainz on nectar so 4k or so is but a mere irritant But still!
1 · Reply
Dipshit101
Dipshit101 Apr. 3 at 5:37 PM
$ADAPY please someone explained to the dipshits, what’s the process here, when/if the outcome is one we get paid, Is it put in our accounts? Or does the share prices just go up and we decide when to sell ?
1 · Reply
US_Bull
US_Bull Apr. 3 at 2:53 PM
$ADAPY Look under IND enabling for both us and them (their's is undisclosed) is it supposed to be ADAPY's. https://www.greywolftherapeutics.com/pipeline https://www.adaptimmune.com/pipeline
0 · Reply
US_Bull
US_Bull Apr. 3 at 2:45 PM
$ADAPY Whole premise of Adaptimmune is to target MAGE, PRAME, and CD70
1 · Reply
US_Bull
US_Bull Apr. 3 at 2:43 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Apr. 3 at 2:40 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Apr. 3 at 2:39 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Apr. 3 at 2:39 PM
$ADAPY The more DD I do on Greywolf therapeutics and understanding their MOA the more it makes sense if they are up to something with us. Their MOA is based on ERAP-1 and ERAP-2 blocking. These proteins are involved in forming neoantigens by being blocked to be presented by the tumor cells to more efficiently kill them. In other words the immune system sees a whole new repertoire of immunogenic epitopes, which have a direct link to MAGE and PRAME cancer targets.
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Apr. 3 at 1:00 PM
$ADAPY Ok that ADR fee is only 8% of the total value of the shares, which, of course, was already priced in. Plus, think of all that value you get for your 8%. The list is endless.
1 · Reply
US_Bull
US_Bull Apr. 3 at 11:30 AM
$ADAPY Good to see that ADR's are being collected from here and there still nothing on Schwab from my end maybe it means that we can all soon get paid.
0 · Reply
Bearhunter00769
Bearhunter00769 Apr. 3 at 12:04 AM
$ADAPY etrade adr fee taken out as of 8 pm
3 · Reply
Mmalone427
Mmalone427 Apr. 2 at 10:49 PM
$ADAPY looks like the ADR fees will most likely be deducted on April 10 or 13. Looking at other stocks with ADR fees, they are roughly processed 10 days after the recorded date. We shall see.
3 · Reply
PaidPiper
PaidPiper Apr. 2 at 10:22 PM
$ADAPY not a big deal but as of April 1st, ADAP is 100% compliant with PCAOB. Means we have no past-due accounting support fees. Probably makes purchasing 5% easier now that the report is officially out.
1 · Reply
Wildblitz
Wildblitz Apr. 2 at 6:00 PM
$ADAPY When?
2 · Reply
PaidPiper
PaidPiper Apr. 2 at 5:47 PM
$ADAPY there's 7 companies registered at 99 park drive. Maybe we're partnering with all of them?
2 · Reply
Stockinvestor73
Stockinvestor73 Apr. 2 at 4:15 PM
$ADAPY
0 · Reply
BSinvests
BSinvests Apr. 2 at 4:02 PM
$ADAPY
1 · Reply
952_
952_ Apr. 2 at 3:15 PM
$ADAPY happy easter. May the force be with u
0 · Reply